91桃色

Journal of Dementia
Open 91桃色

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open 91桃色 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open 91桃色 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Understanding Memory Loss in Alzheimer's Disease: From Molecular Mechanisms to Therapeutic Approaches

Haruka Takahashi*
Department of Occupational Therapy, Tehran University of Social Welfare and Rehabilitation Sciences (USWR), Iran
*Corresponding Author: Haruka Takahashi, Department of Occupational Therapy, Tehran University of Social Welfare and Rehabilitation Sciences (USWR), Iran, Email: hashiharu004@gmail.com

Received Date: Jan 01, 2025 / Published Date: Jan 30, 2025

Citation: Haruka T (2025) Understanding Memory Loss in Alzheimer’s Disease:From Molecular Mechanisms to Therapeutic Approaches J Dement 9: 262.

Copyright: © 2025 Haruka T. This is an open-access article distributed under theterms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.

 
To read the full article Peer-reviewed Article PDF image

Abstract

Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by progressive cognitive decline and memory loss. The underlying molecular mechanisms contributing to memory impairment in AD remain an area of intense research. This review explores the key factors contributing to memory loss, including amyloid-beta plaques, tau tangles, neuroinflammation, and synaptic dysfunction. We also highlight emerging therapeutic strategies targeting these mechanisms, ranging from amyloid-targeting antibodies to novel approaches that aim to regulate tau pathology and neuroinflammation. Current treatments are limited to symptom management, and there is an urgent need for diseasemodifying therapies. We discuss the promise of potential treatments, including immunotherapies, small molecule inhibitors, and gene therapy, with an emphasis on clinical trial outcomes. This review aims to provide a comprehensive overview of AD-related memory loss, from molecular understanding to therapeutic interventions, offering insights into future directions for research and clinical practice.

Recommended Conferences

Toronto, Canada
Citations : 5

Indexed In
  • Google Scholar
  • ICMJE
Share This Page
International Conferences 2025-26
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top